These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 34965557

  • 41. [Outcome of children cured of acute lymphoblastic leukemia].
    Tabone MD, Leverger G.
    Bull Acad Natl Med; 2009 Oct; 193(7):1519-28. PubMed ID: 20669633
    [Abstract] [Full Text] [Related]

  • 42. [Late sequelae of central nervous system prophylaxis in children with acute lymphoblastic leukemia: high doses of intravenous methotrexate versus radiotherapy of the central nervous system--review of literature].
    Zając-Spychała O, Wachowiak J.
    Med Wieku Rozwoj; 2012 Oct; 16(2):128-37. PubMed ID: 22971657
    [Abstract] [Full Text] [Related]

  • 43. Detection of anti-asparaginase antibodies during therapy with E.coli asparaginase in children with newly diagnosed acute lymphoblastic leukemia and lymphoma.
    Ebeid EN, Kamel MM, Ali BA.
    J Egypt Natl Canc Inst; 2008 Jun; 20(2):127-33. PubMed ID: 20029468
    [Abstract] [Full Text] [Related]

  • 44. Risk of acute childhood leukaemia in Sweden after the Chernobyl reactor accident. Swedish Child Leukaemia Group.
    Hjalmars U, Kulldorff M, Gustafsson G.
    BMJ; 1994 Jul 16; 309(6948):154-7. PubMed ID: 8044093
    [Abstract] [Full Text] [Related]

  • 45. An intensive re-treatment protocol for children with an isolated CNS relapse of acute lymphoblastic leukemia.
    Ribeiro RC, Rivera GK, Hudson M, Mulhern RK, Hancock ML, Kun L, Mahmoud H, Sandlund JT, Crist WM, Pui CH.
    J Clin Oncol; 1995 Feb 16; 13(2):333-8. PubMed ID: 7844594
    [Abstract] [Full Text] [Related]

  • 46. Growth and puberty after treatment for acute lymphoblastic leukemia.
    Alves CH, Kuperman H, Dichtchekenian V, Damiani D, Della Manna T, Cristófani LM, Odone Filho V, Setian N.
    Rev Hosp Clin Fac Med Sao Paulo; 2004 Apr 16; 59(2):67-70. PubMed ID: 15122420
    [Abstract] [Full Text] [Related]

  • 47. A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation.
    Hill JM, Kornblith AB, Jones D, Freeman A, Holland JF, Glicksman AS, Boyett JM, Lenherr B, Brecher ML, Dubowy R, Kung F, Maurer H, Holland JC.
    Cancer; 1998 Jan 01; 82(1):208-18. PubMed ID: 9428499
    [Abstract] [Full Text] [Related]

  • 48. DRIVERS OF HYPERFERREMIA IN CHILDREN LIVING ON RADIOLOGICALLY CONTAMINATED TERRITORIES AFTER THE CHNPP ACCIDENT IN UKRAINE.
    Bazyka DA, Bruslova KM, Liashenko LO, Pushkareva TI, Tsvyetkova NM, Galkina SG, Kondrashova VG, Yaroshenko ZS, Gonchar LO, Yatsemyrskyi SM, Trychlіb IV, Kavardakova NV, Boyarskyi VG, Chernysh TO, Lytvynets OM.
    Probl Radiac Med Radiobiol; 2023 Dec 01; 28():239-253. PubMed ID: 38155126
    [Abstract] [Full Text] [Related]

  • 49. Differential effects of radiotherapy on growth and endocrine function among acute leukemia survivors: a childhood cancer survivor study report.
    Chow EJ, Liu W, Srivastava K, Leisenring WM, Hayashi RJ, Sklar CA, Stovall M, Robison LL, Baker KS.
    Pediatr Blood Cancer; 2013 Jan 01; 60(1):110-5. PubMed ID: 22628201
    [Abstract] [Full Text] [Related]

  • 50. Long-term thyroid disorders in pediatric survivors of hematopoietic stem cell transplantation after chemotherapy-only conditioning.
    Cima LN, Martin SC, Lambrescu IM, Stejereanu L, Zaharia C, Colita A, Fica S.
    J Pediatr Endocrinol Metab; 2018 Aug 28; 31(8):869-878. PubMed ID: 29935114
    [Abstract] [Full Text] [Related]

  • 51. Cerebral glucose metabolism in survivors of childhood acute lymphoblastic leukemia.
    Kähkönen M, Metsähonkala L, Minn H, Utriainen T, Korhonen T, Norvasuo-Heilä MK, Harila-Saari A, Aärimaa T, Suhonen-Polvi H, Ruotsalainen U, Solin O, Salmi TT.
    Cancer; 2000 Feb 01; 88(3):693-700. PubMed ID: 10649265
    [Abstract] [Full Text] [Related]

  • 52. Second thyroid neoplasms after prophylactic cranial irradiation for acute lymphoblastic leukemia.
    Perel Y, Leverger G, Carrere A, Caudry M, Garabedian EN, Ansoborlo S, Vergnes P.
    Am J Hematol; 1998 Sep 01; 59(1):91-4. PubMed ID: 9723585
    [Abstract] [Full Text] [Related]

  • 53. [The effect of Chernobyl accident on the development of malignant diseases--situation after 20 years].
    Zonenberg A, Zarzycki W, Leoniak M.
    Endokrynol Pol; 2006 Sep 01; 57(3):244-52. PubMed ID: 16832789
    [Abstract] [Full Text] [Related]

  • 54. Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: comparison of megadose methylprednisolone and conventional-dose prednisolone treatments.
    Alikasifoglu A, Yetgin S, Cetin M, Tuncer M, Gumruk F, Gurgey A, Yordam N.
    Am J Hematol; 2005 Oct 01; 80(2):113-8. PubMed ID: 16184587
    [Abstract] [Full Text] [Related]

  • 55. Late thyroid complications in survivors of childhood acute leukemia. An L.E.A. study.
    Oudin C, Auquier P, Bertrand Y, Chastagner P, Kanold J, Poirée M, Thouvenin S, Ducassou S, Plantaz D, Tabone MD, Dalle JH, Gandemer V, Lutz P, Sirvent A, Villes V, Barlogis V, Baruchel A, Leverger G, Berbis J, Michel G.
    Haematologica; 2016 Jun 01; 101(6):747-56. PubMed ID: 26969082
    [Abstract] [Full Text] [Related]

  • 56. Measures of thyroid function among Belarusian children and adolescents exposed to iodine-131 from the accident at the Chernobyl nuclear plant.
    Ostroumova E, Rozhko A, Hatch M, Furukawa K, Polyanskaya O, McConnell RJ, Nadyrov E, Petrenko S, Romanov G, Yauseyenka V, Drozdovitch V, Minenko V, Prokopovich A, Savasteeva I, Zablotska LB, Mabuchi K, Brenner AV.
    Environ Health Perspect; 2013 Jul 01; 121(7):865-71. PubMed ID: 23651658
    [Abstract] [Full Text] [Related]

  • 57. Outcomes of a randomized trial of hyperfractionated cranial radiation therapy for treatment of high-risk acute lymphoblastic leukemia: therapeutic efficacy and neurotoxicity.
    Waber DP, Silverman LB, Catania L, Mautz W, Rue M, Gelber RD, Levy DE, Goldwasser MA, Adams H, Dufresne A, Metzger V, Romero I, Tarbell NJ, Dalton VK, Sallan SE.
    J Clin Oncol; 2004 Jul 01; 22(13):2701-7. PubMed ID: 15226337
    [Abstract] [Full Text] [Related]

  • 58. Can protocol-specified doses of chemotherapy and radiotherapy be used as a measure of treatment actually received? A CCG/NIH study on long-term survivors of acute lymphocytic leukemia.
    Haupt R, Novakovic B, Fears TR, Byrne J, Robinson LL, Tucker MA, Reaman GH.
    J Clin Epidemiol; 1996 Jun 01; 49(6):687-90. PubMed ID: 8656231
    [Abstract] [Full Text] [Related]

  • 59. Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study cohort.
    Essig S, Li Q, Chen Y, Hitzler J, Leisenring W, Greenberg M, Sklar C, Hudson MM, Armstrong GT, Krull KR, Neglia JP, Oeffinger KC, Robison LL, Kuehni CE, Yasui Y, Nathan PC.
    Lancet Oncol; 2014 Jul 01; 15(8):841-51. PubMed ID: 24954778
    [Abstract] [Full Text] [Related]

  • 60. Acute Central Nervous System Complications in Pediatric Acute Lymphoblastic Leukemia.
    Baytan B, Evim MS, Güler S, Güneş AM, Okan M.
    Pediatr Neurol; 2015 Oct 01; 53(4):312-8. PubMed ID: 26202590
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.